Celisa McGrone
Family · Yakima, WANPI 1770035248
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 26.3% of the total. Among family clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$748
- Lilly USA, LLC$366
- Astellas Pharma US Inc$270
- Bayer$237
- AstraZeneca$235
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,97198%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,069 |
| Novo Nordisk | 42 | $748 |
| Lilly USA, LLC | 21 | $366 |
| Astellas Pharma US Inc | 11 | $270 |
| Bayer | 12 | $237 |
| AstraZeneca | 13 | $235 |
| Pfizer | 11 | $215 |
| Amgen | 7 | $116 |
| GSK | 5 | $109 |
| Exact Sciences | 4 | $93 |
| Esperion Therapeutics, Inc. | 3 | $72 |
| Abbott | 4 | $68 |
| Jazz Pharmaceuticals Inc. | 3 | $56 |
| Boehringer Ingelheim | 3 | $56 |
| Merck | 3 | $40 |
| Dexcom, Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Alvogen Inc | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Linus Health, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Novartis | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,070 in reported general payments places this provider in the 95th percentile of 1,706 family providers in Washington.
Other family in Yakima
- Sarah PerlmanYakima$12K
- Tesa LinstadYakima$8K
- Melanie AdamsYakima$7K
- Frances HullYakima$6K
- Sharla PetersonKenmore$192K
- Zelda SwainSpokane$83K
- Savannah MorganRenton$76K
- Kevan PettersonSeattle$56K
- Kelly McFeeSunnyside$42K
- Cheryl SomersSpokane$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.